Disease | multiple endocrine neoplasia type 1 |
Comorbidity | C0024623|gastric cancers |
Sentences | 1 |
PubMedID- 24728052 | The her2 inhibiting antibody trastuzumab successfully improves prognosis when added to the chemotherapy regimen in patients with her2-positive advanced gastric cancers [20]. |
Page: 1